You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple (4-10)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Metastases, Adult Trial in Leuven (Stereotactic radiotherapy)

Recruiting
  • Brain Metastases, Adult
  • Stereotactic radiotherapy
  • Leuven, Belgium
    UZLeuven
Oct 21, 2021

Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial (3x10(6) CART-38 cellls, 7x10(5) CART-38 cells, 7x10(6) CART-38 cells)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Multiple Myeloma (MM)
  • 3x10(6) CART-38 cellls
  • +5 more
  • (no location specified)
Jul 15, 2022

Healthy Trial in London (NTP42:KVA4, Placebo)

Completed
  • Healthy
  • London, United Kingdom
    Hammersmith Medicines Research
Feb 23, 2022

Healthy Trial in Adelaide (ENN0403 1mg, ENN0403 4mg, ENN0403 10mg)

Completed
  • Healthy
  • ENN0403 1mg
  • +9 more
  • Adelaide, Australia
    CMAX Clinical Research Pty Ltd
Aug 17, 2022

Advanced Multiple Sclerosis, Progressive Multiple Sclerosis Trial in United Kingdom (Cladribine (MAVENCLAD®), Placebo)

Recruiting
  • Advanced Multiple Sclerosis
  • Progressive Multiple Sclerosis
  • Cladribine (MAVENCLAD®)
  • Placebo
  • Belfast, United Kingdom
  • +18 more
Jun 9, 2022

Secondary Progressive Multiple Sclerosis (SPMS) Trial in United Kingdom (Simvastatin, Placebo)

Active, not recruiting
  • Secondary Progressive Multiple Sclerosis (SPMS)
  • Belfast, United Kingdom
  • +23 more
Jul 4, 2022

Multiple Myeloma Trial in United Kingdom (Pomalidomide, Dexamethasone, Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • Belfast, United Kingdom
  • +20 more
May 24, 2022

Non-Hodgkin's Lymphoma, Myeloma, Active Solid Malignancy Trial in New York (PET Imaging using 124 IPUH71)

Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • PET Imaging using 124 IPUH71
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 10, 2023

Obesity Trial in Daegu, Seoul (HSG4112, Placebo)

Completed
  • Obesity
  • Daegu, Korea, Republic of
  • +1 more
Jul 27, 2022

Obesity Trial in Seoul (HSG4112, Placebo)

Recruiting
  • Obesity
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jul 27, 2022

Multiple Myeloma Trial in Shanghai (Osalmid)

Active, not recruiting
  • Multiple Myeloma
  • Shanghai, Shanghai, China
    Shanghai 10th People's Hospital
May 17, 2021

Drug-Drug Interaction Trial in Porto (ITF2357 Givinostat 10mg/mL, Midazolam 1Mg/Ml (Pf) Inj Syringe 5Ml, Midazolam Oral Liquid

Completed
  • Drug-Drug Interaction
  • ITF2357 Givinostat 10mg/mL
  • +4 more
  • Porto, Portugal
    Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Aug 4, 2022

Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

Recruiting
  • Solid Tumor
  • +11 more
  • Belfast, United Kingdom
  • +16 more
Mar 2, 2023

Multiple Sclerosis Trial in Cairo (Dalfampridine ER, 10 Mg Oral Tablet, Extended Release, Placebo)

Recruiting
  • Multiple Sclerosis
  • Dalfampridine ER, 10 Mg Oral Tablet, Extended Release
  • Placebo
  • Cairo, Egypt
    Ain Shams Univeristy
Feb 15, 2023

Migraine Trial (Zavegepant 10 mg, Placebo - Control 1, Placebo - Control 2)

Not yet recruiting
  • Migraine
  • Zavegepant 10 mg
  • +2 more
  • (no location specified)
Oct 22, 2023

Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

Not yet recruiting
  • Diabetes Mellitus Type 2 With Proteinuria
  • +12 more
  • Empagliflozin 10 MG
  • +6 more
  • (no location specified)
Oct 17, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in Porto Alegre (Cladribine 10 mg oral tablet)

Active, not recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Cladribine 10 mg oral tablet
  • Porto Alegre, RS, Brazil
    Pontifical Catholic University of Rio Grande do Sul
Jun 5, 2023

Multiple Sclerosis, Fatigue Trial (4-week Relaxation Training, 4-week Behavioral Activation, 4-week Cognitive Therapy)

Not yet recruiting
  • Multiple Sclerosis
  • Fatigue
  • 4-week Relaxation Training
  • +2 more
  • (no location specified)
Apr 27, 2023

Obesity Trial in Daegu, Seoul (HSG4112, Placebo)

Completed
  • Obesity
  • Daegu, Korea, Republic of
  • +1 more
Oct 25, 2021

Multiple Sclerosis Trial in Boston (drug, behavioral, other)

Not yet recruiting
  • Multiple Sclerosis
  • Dalfampridine 10 MG [Ampyra]
  • +2 more
  • Boston, Massachusetts
    MGH Institute of Health Professions
Nov 13, 2023

Ultra-high-field Brain MRI in Multiple Sclerosis

Not yet recruiting
  • Multiple Sclerosis
  • Brain MRI (3T, 7T, 9.4T)
  • Geleen, Limburg, Netherlands
    Zuyderland MC
Jan 30, 2023

Type 2 Diabetes Trial in Beijing (HS-20094 5mg, HS-20094 10mg, HS-20094 15mg)

Recruiting
  • Type 2 Diabetes
  • HS-20094 5mg
  • +3 more
  • Beijing, Beijing, China
    Peking University First Hospital
Nov 3, 2023

Chemo-induced Diarrhea Trial in Glendale (SK10, Placebo)

Recruiting
  • Chemotherapy-induced Diarrhea
  • Glendale, California
    Early Phase Clinical Unit (EPCU) - PAREXEL
Aug 30, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Durvalumab, Pomalidomide)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +43 more
Jun 9, 2022

Multiple Sclerosis: FutureMS-2 -Observational Cohort and

Enrolling by invitation
  • Multiple Sclerosis
    • Aberdeen, United Kingdom
    • +4 more
    Aug 18, 2023